![Winston Kung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Winston Kung
Directeur Financier/CFO chez
ARRIVENT BIOPHARMA, INC.
Fortune : 132 502 $ au 31/05/2026
Profil
Winston W.
Kung is the founder of Alliance Management Group.
Mr. Kung is currently an Independent Director at Janux Therapeutics, Inc. since 2022, an Independent Director at Corbus Pharmaceuticals Holdings, Inc. since 2024, and Chief Financial Officer & Treasurer at Arrivent BioPharma, Inc. since 2024.
Formerly, Mr. Kung was Chief Operating & Financial Officer at PMV Pharmaceuticals, Inc. from 2017 to 2024, VP-Business Development & Global Alliances at Celgene Corp.
from 2013 to 2017, Chief Business Officer at Celgene Cellular Therapeutics from 2013 to 2015, Director-Global Healthcare at Citigroup, Inc. from 2010 to 2013, Vice President-Global Mergers & Acquisitions at Lehman Brothers, Inc. from 2007 to 2010, Principal at Amgen, Inc. from 2004 to 2007, Director at Alliqua BioMedical, Inc. from 2016 to 2017, and Director at Aitia, Inc. Education includes undergraduate studies at Brown University and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 12 140 ( 0,07 % ) | 96 027 $ | 31/05/2026 | |
| 11/06/2026 | 2 500 ( 0 % ) | 36 475 $ | 31/05/2026 | |
| 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Winston Kung
| Sociétés | Poste | Début |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/09/2022 |
| ARRIVENT BIOPHARMA, INC. | Directeur Financier/CFO | 01/01/2024 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 16/08/2024 |
Anciens postes connus de Winston Kung
| Sociétés | Poste | Fin |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Directeur Financier/CFO | 04/01/2024 |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Operates as a biomedical company | Directeur/Membre du Conseil | 24/11/2017 |
| CELGENE | Corporate Officer/Principal | 01/11/2017 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Corporate Officer/Principal | 01/02/2015 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/04/2013 |
Formation de Winston Kung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Operates as a biomedical company | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Alliance Management Group
 Alliance Management Group Real Estate DevelopmentFinance Provides property management | Finance |
